MedTrace Logo

SCP® Observational Study of the Knee

NCT03110224 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 516

Last updated 2025-10-28

Study results available
· View outcomes & findings →

Summary

Post Market clinical outcomes study to collect data on the short - and long-term outcomes for subjects who are undergoing or who have undergone the Subchondroplasty (SCP) Procedure in the knee in a standard clinical setting. Outcomes to be assessed include pain medication usage, pain, function, activity levels and patient satisfaction.

Conditions

  • Bone Marrow Edema

Interventions

DEVICE

Subchondroplasty Procedure with AccuFill

Injection of the commercially available flowable calcium phosphate (CaP) synthetic bone-void filler, AccuFill®, into subchondral bone defects in the knee(Subchondroplasty (SCP) Procedure).

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Charles Jaggard · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-18
Primary Completion
2020-09-16
Completion
2023-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03110224 on ClinicalTrials.gov